Post-diagnosis Soy Food Intake and Breast Cancer Survival: A Meta-analysis of Cohort Studies |
Chi, Feng
(Department of Medical Oncology, Shengjing Hospital of China Medical University)
Wu, Rong (Department of Medical Oncology, Shengjing Hospital of China Medical University) Zeng, Yue-Can (Department of Medical Oncology, Shengjing Hospital of China Medical University) Xing, Rui (Department of Medical Oncology, Shengjing Hospital of China Medical University) Liu, Yang (Department of Medical Oncology, Shengjing Hospital of China Medical University) Xu, Zhao-Guo (Department of Medical Oncology, Shengjing Hospital of China Medical University) |
1 | Boyapati SM, Shu XO, Zhi XR, et al (2005). Soyfood intake and breast cancer survival: A followup of the Shanghai Breast Cancer Study. Breast Cancer Res Treat, 92, 11-7. DOI |
2 | Brooks JD, Thompson LU (2005). Mammalian lignans and genistein decrease the activities of aromatase and 17betahydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol, 94, 461-7. DOI ScienceOn |
3 | Caan BJ, Natarajan L, Parker B, et al (2011). Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev, 20, 854-8. DOI ScienceOn |
4 | Constantinou AI, Lantvit D, Hawthorne M, et al (2001). Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. Nutr Cancer, 41, 75-81. DOI ScienceOn |
5 | Constantinou AI, White BEP, Tonetti D, et al (2005). The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours. Europ J Cancer, 41, 647-54. DOI ScienceOn |
6 | Dong JY, Qin LQ (2011). Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat, 125, 315-23. DOI ScienceOn |
7 | Doyle C, Kushi LH, Byers T, et al (2006). Nutrition and physical activity during and after cancer treatment: An American Cancer Society guide for informed choices. CA Cancer J Clin, 56, 323-53. DOI ScienceOn |
8 | Enderlin CA, Coleman EA, Stewart CB, et al (2009). Dietary soy intake and breast cancer risk. Oncol Nurs Forum, 36, 531-9. DOI ScienceOn |
9 | Fink BN, Steck SE, Wolff MS, et al (2007). Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol Biomarkers Prev, 16, 2285-92. DOI ScienceOn |
10 | Guha N, Kwan ML, Quesenberry Jr CP, et al (2009). Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: The Life after Cancer Epidemiology study. Breast Cancer Res Treat, 118, 395-405. DOI ScienceOn |
11 | Harris PF, Remington PL, Trentham-Dietz A, et al (2002). Prevalence and Treatment of Menopausal Symptoms Among Breast Cancer Survivors. Journal of Pain and Symptom Management, 23, 501-9. DOI ScienceOn |
12 | Kang X, Zhang Q, Wang S, et al (2010). Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy. CMAJ, 182, 1857-62. DOI ScienceOn |
13 | Helferich WG, Andrade JE, Hoagland MS (2008). Phytoestrogens and breast cancer: a complex story. Inflammopharmacology, 16, 219-26. DOI ScienceOn |
14 | Jones JL, Daley BJ, Enderson BL, et al (2002). Genistein inhibits tamoxifen effects on cell proliferation and cell cycle arrest in T47D breast cancer cells. Am Surg, 68, 575-7; discussion 577-8. |
15 | Ju YH, Doerge DR, Woodling KA, et al (2008). Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis, 29, 2162-8. DOI ScienceOn |
16 | Lacey M, Bohday J, Fonseka SM, et al (2005). Dose-response effects of phytoestrogens on the activity and expression of 3beta-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells. J Steroid Biochem Mol Biol, 96, 279-86. DOI ScienceOn |
17 | Li L, Li J, Yang K, et al (2010). Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer. Future Oncol, 6, 201-7. DOI ScienceOn |
18 | Liu B, Edgerton S, Yang X, et al (2005). Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Cancer Res, 65, 879-86. |
19 | Messina MJ, Loprinzi CL (2001). Soy for breast cancer survivors: a critical review of the literature. J Nutr, 131, 3095S-108S. |
20 | Moon YJ, Wang X, Morris ME (2006). Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro, 20, 187-210. DOI ScienceOn |
21 | Morris KT, Johnson N, Homer L, Walts D (2000). A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg, 179, 407-11. DOI ScienceOn |
22 | Qin LQ, Xu JY, Wang PY, et al (2006). Soyfood intake in the prevention of breast cancer risk in women: a meta-analysis of observational epidemiological studies. J Nutr Sci Vitaminol (Tokyo), 52, 428-36. DOI ScienceOn |
23 | Nakata T, Takashima S, Shiotsu Y, et al (2003). Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients. J Steroid Biochem Mol Biol, 86, 455-60. DOI ScienceOn |
24 | Nechuta SJ, Caan BJ, Chen WY, et al (2012). Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr, 96, 123-32. DOI |
25 | Pasqualini JR, Chetrite GS (2005). Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol, 93, 221-36. DOI ScienceOn |
26 | Santell RC, Chang YC, Nair MG, et al (1997). Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr, 127, 263-9. |
27 | Schwartz JA, Liu G, Brooks SC (1998). Genistein-mediated attenuation of tamoxifen-induced antagonism from estrogen receptor-regulated genes. Biochem Biophys Res Commun, 253, 38-43. DOI ScienceOn |
28 | Shu XO, Zheng Y, Cai H, et al (2009). Soy food intake and breast cancer survival. JAMA, 302, 2437-43. DOI ScienceOn |
29 | Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283, 2008-12. DOI ScienceOn |
30 | Tanos V, Brzezinski A, Drize O, et al (2002). Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro. Eur J Obstet Gynecol Reprod Biol, 102, 188-94. DOI ScienceOn |
31 | Wang TTY, Sathyamoorthy N, Phang JM (1996). Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis, 17, 271-5. DOI ScienceOn |
32 | Taylor CK, Levy RM, Elliott JC, et al (2009). The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. Nutr Rev, 67, 398-415. DOI ScienceOn |
33 | Trock BJ, Hilakivi-Clarke L, Clarke R (2006). Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst, 98, 459-71. DOI ScienceOn |
34 | Velentzis LS, Woodside JV, Cantwell MM, et al (2008). Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know. Eur J Cancer, 44, 1799-806. DOI ScienceOn |
35 | Zhang YF, Kang HB, Li BL, et al (2012). Positive effects of soy isoflavone food on survival of breast cancer patients in China. Asian Pac J Cancer Prev, 13, 479-82. 과학기술학회마을 DOI ScienceOn |
![]() |